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Abstract 
Skin conditions may have a strong impact on sexual life of patients, and thus influence personal 
relationships. Sexual issues are difficult to discuss directly in clinical practice, and a mediated 
instrument may be useful to capture such information. In this study the item 9 of the Dermatology 
Life Quality Index was used to collect information on sexual impact of several skin conditions in 13 
European countries. Among 3485 patients, 23.1% reported sexual problems. The impairment was 
particularly high in patients with hidradenitis suppurativa, prurigo, blistering disorders, psoriasis, 
urticaria, eczema, infections of the skin, pruritus. Sexual impact was strongly associated with 
depression, anxiety, and suicidal ideation. It was generally more frequent in younger patients and 
positively correlated to clinical severity and itch. It is important to address the issue of sexual well-
being in the evaluation of patients with skin conditions, since it is often linked to anxiety, 
depression, and even suicidal ideation. 
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Introduction 
Sexual life is an important component of health-related quality of life. Skin conditions may have a 
strong impact on this component, since they involve the appearance, and thus social life and 
personal relationships. Several studies have investigated the impact of venereological and 
dermatological diseases with genital localization on sexual life (1,2,3). However, regardless of the 
localization of the affected body area, the involvement of skin in a disease may have consequences 
on intimacy (4,5).  
In clinical practice, it may be challenging for both the patient and the physician to discuss sensitive 
issues directly, so the impact of a disease on sexual life is rarely assessed. Self-assessment using 
questionnaires may provide a viable alternative. Several specific questionnaires aimed at measuring 
sexual quality of life are available (6), and even a single question from a generic or disease specific 
quality of life instrument may yield some important information.  
A relevant issue in the interpretation of studies on quality of life in general, and of the impact of 
skin diseases on sexual life, derives from the vast cultural and methodological variations between 
countries and study design, as well from the use of different questionnaires.  
Therefore, we planned a multicenter European initiative to provide insight on the impact of skin 
diseases on quality of life and psychological wellbeing, using a single study design with 
standardized procedures and common research tools (7). The aim of the present study was to 
investigate the perceived impact of several dermatological conditions on patients’ sexual life, using 
item 9 of the Dermatology Life Quality Index (DLQI) (8), across clinical and demographic 
variables in thirteen European  countries.  
 
Methods 
Data presented in this report come from a large, cross-sectional study on the psychological burden 
of skin diseases conducted in 13 European countries. Materials and methods were described in 
detail in the main paper (7). In brief, complete data were collected on 3635 consecutive, 
dermatological out-patients, and 1359 healthy controls. The present report, being focused on the 
impact of skin diseases on the patients’ sexual life, is based on data collected from the dermatology-
specific instrument DLQI, and therefore considers only the out-patients sample. The inclusion 
criteria were age from 18 years and up, being able to read and write the local language, and not 
suffering from severe psychiatric diseases. Each patient was examined by a dermatologist who 
recorded the diagnosis and the presence of other physical conditions. Patients completed a 
questionnaire including socio-demographic variables. The Hospital Anxiety and Depression Scale 
(HADS) (9,10) was used to evaluate the presence and severity of depression and/or anxiety in 
patients. It includes seven items assessing anxiety and seven assessing depression, each with four 
possible answers. For each dimension of anxiety and depression a score from 0 to 7 is considered a 
normal case, from 8 to 10 a borderline case, and from 11 to 21 a case in need of further examination 
or treatment. The clinical severity of the skin condition was evaluated by the physician as either 
“mild”, “moderate”, or “severe”.  
The sexual impact due to the skin condition was evaluated using item 9 of the DLQI (8). The 
question is “Over the last week, how much has your skin caused any sexual difficulties?”, with the 
possible answers “very much” (3), “a lot” (2), “a little” (1), “not at all/not relevant” (0).  
We calculated the frequency of each answer for the different dermatological conditions, and we 
studied the association of sexual impairment with different variables, including socio-demographic 
(gender, age, “living in the country of origin”, education, marital status, geographical region) and 
clinical information (clinical severity of the skin condition, body site, and itch). The answers of item 
9 were grouped to have a  dichotomous variable “yes/no” (answers “very much” [3], “a lot” [2], and 
“a little” [1] versus “not at all/not relevant” [0]) or “very much or a lot/other”  (answers “very 
much” [3] and “a lot” [2] versus “a little” [1] and “not at all/not relevant” [0]). Countries were 
grouped into Northern Europe (Denmark, Norway), Western Europe (Belgium, France, Germany, 
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The Netherlands, UK), Eastern Europe (Hungary, Poland, Russia, Turkey), and Southern Europe 
(Italy, Spain). Frequencies were compared using the chi-square test.  
Logistic regression models were tested for some diseases selected on the basis of the number of 
patients (eczema, psoriasis, acne), and/or the strong prevalence of sexual problems (blistering 
disorders). The diagnosis “eczema” included atopic dermatitis, eczema, and hand eczema. The 
dicothomousdichotomous variable DLQI_9 (presence/absence of sexual difficulties) was introduced 
in each model as the dependent variable . The independent variables were  age, gender, clinical 
severity, European region, flare on scalp, flare on hands, itch, anxiety, and depression.  
 
Results 
Data were complete for both question 9 of the DLQI and diagnosis in 3485 patients. The 114 
patients with a diagnosis, but with no answer to the question 9 of the DLQI were older than patients 
who answered the question (mean age 56.8 vs 46.8 among patients who did not answer and who 
answered question 9, respectively, p <0.001), and included more women (65.8% vs 56.1%, 
p=0.027). Overall, 11.7% of patients reported sexual difficulties “a little”, 5.5% “a lot”, and 5.9% 
“very much”. Spearman’s correlation between item 9 and the DLQI total score was 0.558. We also 
verified the correlation between item 9 and the sum of all the other DLQI items: the Spearman’s 
correlation coefficient remained in the “moderate” range, although at a lower level (i.e., 0.501). 
As shown in Table 1, there was no significant difference between men and women, while sexual 
impairment was reported more frequently by younger patients. No differences were observed in 
patients with different marital status and different origin (i.e., either coming from a foreign country 
or not). In Southern countries the prevalence of sexual difficulties was significantly higher 
compared to the other geographical areas. In patients with a clinically severe condition, the 
prevalence of  sexual problems was three times more frequent among patients answering “a lot”, 
and four time more frequent for those answering “very much” compared to patients with a clinically 
mild condition. Also flares on scalp and on hands, as well as itch, were  significantly associated 
withto sexual problems.  
Sexual difficulties were strongly associated with both depression and anxiety (Table 2). For 
example, among depressed patients, 24.3% reported sexual difficulties “a lot” or “very much”, 
compared to 7.3% of non-depressed patients. For anxiety the percentages were respectively 20.7% 
and 5.9%. Among patients who reported thoughts of suicide due to their skin condition 30.5% 
reported sexual difficulties “very much”, compared to 9.9% of patients who did not have thoughts 
of suicide. 
As shown in Figure 1, which summarizes the prevalence of the answers “a lot/very much/a little” to 
question 9 of the DLQI, the impairment was particularly high in patients with hidradenitis 
suppurativa (66.7%). Other diagnoses with a prevalence greater than 1/3 were prurigo (41.7%), 
blistering disorders (34.9%), and psoriasis (34.8%); these were followed by urticaria  and eczema 
(both at 29.0%), infections of the skin (27.7%), and pruritus (27.6%). The lowest prevalence was 
reported by patients with non-melanoma skin cancer (6.1%), nevi (6.4%), benign skin tumours 
(10.8%), and melanoma (12.8%).  
When looking at the role of gender in the different skin conditions, it was observed that in patients 
with acne the impact on sexual life was higher in men than in women (23.5% of positive answers to 
item 9 and 12.2%, respectively, p<0.05). For all the other conditions, the difference between men 
and women was not significant. The higher impact on sexual life observed overall in younger 
patients was significant only in patients with psoriasis (38.2% of positive answers in patients up to 
60 years old, and 21.6% in patients older than 60, p<0.05), with blistering disorders (47.1% and 
23.1%, respectively, p<0.05), and with eczema (31.5% and 16.0%, respectively, p<0.05). 
In patients with eczema (Table 3), sexual difficulties were significantly associated with young age, 
high severity, itch, anxiety and depression. In patients with psoriasis, sexual impairment was 
associated with young age, itch, anxiety, and depression. In patients with acne, sexual impact was 
associated with gender (higher impact in men), flare on hands, and itch. As for blistering diseases, 
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because of the small number of patients, significance was reached only for clinical severity. 
However, there was a strong association between sexual impact and young age.  
It was not possible to test the model for hidradenitis suppurativa, because of the low number of 
patients, however a strong association, although not significant, was observed between sexual 
impact and young age, clinical severity, itch, and anxiety.  
 
Discussion 
In this study, the impact of dermatological conditions on sexual life was investigated with simple 
standardized procedures in a large population of dermatological patients recruited in different 
European areas. The impact was particularly high in patients with hidradenitis suppurativa, prurigo, 
blistering disorders, psoriasis, urticaria, eczema, infections of the skin and , pruritus. The important 
impact of hidradenitis suppurativa, which is a chronic, debilitating suppurativee skin disease (11), 
on quality of life and on a wide spectrum of psychophysical aspects (including fatigue, depression, 
stigmatization level, and overall activity) has been documented (12,13), however, as to our 
knowledge, sexual impact had not been specifically evaluated.   
A decreased sexual functioning has been reported in patients with psoriasis (4,14) In both studies, 
sexual impact was evaluated using single questions. In the first study, 40.8% of patients were 
sexually affected based on the question "Do you believe that since the onset of psoriasis your sexual 
activity has declined?". In the other study, sexual life was impaired in 35% to 71% of patients with 
psoriasis, depending on the different aspects covered by questions from different questionnaires. 
Another study (15) showed that psoriasis patients had more orgasmic problems than problems of 
desire, and stated that orgasmic problems might be due to disturbed self-esteem or emotional 
problems rather than severity or localisation of the disease. A study (16) showed that psoriasis had a 
detrimental effect on quality of life and sexual health, in particular when the lesions were localized 
on the genital area, and in women more than in men. In the present study, sexual impact in psoriasis 
patients was significantly associated with young age, itch, anxiety, and depression. The relevant 
role of itch was previously highlightedalready pointed out by Yosipovitch et al. (17RIF) who 
reported that, as result of pruritus, sexual desire of 35% of study participants was decreased or non-
existent. 
The issue of sexual life was also examined from a qualitative point of view in patients with acne, 
psoriasis, and atopic eczema (18). These conditions had adverse effects on participants' self-
perceived sexual attractiveness and self-confidence, and in particular  psoriasis and eczema also had 
marked effects on sexual well-being and on capacity for intimacy.  
Several studies have addressed the sexual life of patients with atopic dermatitis. Misery et al.(5) 
showed that 57.5% of patients with atopic dermatitis noted a decreased sexual desire, and 36.7% of 
their partners reported that the appearance of eczema had an impact on their sexual life. A German 
study showed that the exchange of tenderness in patients with atopic dermatitis and psoriasis was 
significantly reduced (19). Sexual life was studied in detail in patients with vitiligo and chronic 
urticaria (20), who reported experiencing significantly more difficulties in sexual arousal and in 
reaching orgasm than did controls. In a large population of people aged from 15 to 24 years, the 
presence of acne was associated with less frequent sexual intercourses compared to the control 
group (21). Since the adolescents are the main group suffering from acne (22), and our population 
did not include patients under 18 years of age, the impact of acne in total is probably even greater 
than what we observed. Here sexual life was more impaired in men with acne, probably because it 
is easier for women to hide the lesions using make-up.  
 
A possible explanation for all these findings  is not only that the condition may affect the genital 
area and thus result in pain or discomfort, but also that the skin has an erotogenic function, and skin 
lesions can make physical contact difficult. Although this issue may be very burdensome for the 
individual, this problem is rarely addressed during routine dermatological consultations. In the 
6 
 
 
study by Niemeier et al (19), 93% of psoriatics and 96% of the patients with atopic dermatitis 
indicated that their attending physician had never addressed that problem.   
In this study, we observed that sexual impact was strongly associated with itch, depression, anxiety, 
and even suicidal ideation. The cross-sectional nature of the study does not allow the sorting out of 
the complex interrelationship between the onset of disease, itch, the presence of anxiety and/or 
depression, and the sexual problems. Therefore, while it is not possible to draw any conclusion on 
the direction of the association, it is important to be aware that sexual impairment is often a marker 
for depression or anxiety, and even suicidal ideation – and vice versa. Also, the correlation between 
item 9 of the DLQI and the DLQI total score was high, indicating that an impairment in sexual life 
often corresponds with a general impairment in quality of life.  
An important issue is that sexual problems particularly affect young patients. It was observed (23) 
that, for example, the impact of psoriasis on quality of life was particularly noticeable in younger 
patients, while the symptomatic component, due to comorbidities, was more impaired in older 
patients. Sexual life is an important component of well-being, in particular in young people, and it 
is thus particularly impaired when a skin condition is present.  
A limitation of this study is the use of a single simple question which is not specifically validated to 
assess the sexual impact of dermatological conditions, and therefore does not allow one to evaluate 
in detail which aspects of sexual life are impaired.  However, the aim of this study was to highlight 
the problem in general, and further studies are necessary to elucidate the single specific factors 
(such as, for example, shame or anger, or body site of the lesions, such as genital localization of 
rash, pruritus, etc.) that may be associated with a greater impairment of the patients’ sexual life in 
the different skin conditions. Furthermore, other complex symptoms such as pain and itch may be 
adequately screened for by simple questions, identifying and quantifying the problems before 
detailed analysis. 
The results of the study reinforce the idea that it is important to take into account specific 
psychosocial problems, such as sexual life, when assessing severity and treatment efficacy in 
dermatological conditions. Having this screening, sexual impairment question "hidden" in the DLQI 
may make it easier to bring up the subject and address these issues in the clinic. Clinicians should 
be especially aware of the ability of several dermatological conditions to profoundly affect patients' 
sexual well-being, which in turn is often linked to a range of psychological comorbidities . 
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Table 1. Prevalence of sexual difficulties in the study population according to demographic and 
clinical variables.  
Variable Level N* Sexual difficulties (DLQI_9) P-value 
   Not at all/ 
Not relevant 
A little A lot Very much  
   % % % %  
Overall  3485 76.9 11.7 5.5 5.9  
        Gender Male 1524 75.1 13.0 5.6 6.2  
 Female 1950 78.3 10.7 5.3 5.6 ns 
        Age (years) 18-39 1310 73.3 13.1 6.6 7.0  
 40-59 1171 73.7 13.3 6.1 6.8  
 60+ 942 85.8 7.3 3.3 3.6 <0.001 
        Origin Home 3170 77.1 11.8 5.5 5.6  
 Foreign 245 73.1 11.8 6.5 8.6 ns 
        Education Primary 1425 80.2 9.3 4.5 6.0  
 Secondary 1031 73.4 13.5 6.8 6.3  
 University 996 75.9 13.4 5.5 5.2 0.001 
        Marital status Single 846 75.3 13.2 5.6 5.9  
 Married 1914 77.8 11.1 5.3 5.7  
 Divorced 265 73.6 11.3 7.9 7.2  
 Widow 196 83.2 8.7 2.6 5.6 ns 
        Region of  Northern  724 76.0 12.7 5.5 5.8  
Europe Western  1046 83.3 9.0 3.3 4.4  
 Eastern  967 77.4 9.9 6.2 6.5  
 Southern  748 68.4 16.8 7.4 7.4 <0.001 
        Severity Mild 1183 84.7 9.5 3.0 2.9  
 Moderate 1408 72.3 14.4 6.7 6.5  
 Severe 521 65.3 12.9 8.8 13.1 <0.001 
        Flare on face Yes 1262 78.6 11.3 4.6 5.5  
 No 2150 75.3 12.3 6.0 6.3 ns 
        Flare on scalp Yes 908 72.4 13.7 5.7 8.3  
 No 2509 78.1 11.3 5.5 5.2 0.001 
        Flare on hands Yes 1037 70.0 13.7 7.5 8.8  
 No 2379 79.4 11.1 4.7 4.8 <0.001 
        Itch Yes 1863 68.8 15.4 7.6 8.2  
 No 1568 86.2 7.7 2.8 3.3 <0.001 
*Totals may vary because of missing figures
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Table 2. Frequency of sexual difficulties in the study population according to mood disorders. 
 
  Sexual difficulties (DLQI_9) P- value 
 N Not at all A little A lot Very much  
  % % % %  
No depression 2618 82.1 10.6 3.8 3.5  
Marginal or clinical 
depression 
824 60.3 15.4 10.7 13.6 <0.001 
       
No anxiety 2168 84.3 9.8 3.0 2.9  
Marginal or clinical 
anxiety 
1270 64.2 15.0 9.8 10.9 <0.001 
       
No thoughts of suicide  3226 78.6 11.5 4.8 5.1  
Thoughts of suicide  233 54.1 15.5 12.9 17.6 <0.001 
 
 
Table 3. Logistic regression models for eczema, psoriasis, acne, and blistering disorders, with sexual impact as the dependent variables. The Odds 
Ratios (OR) were also adjusted for region.   
  ECZEMA (n=448) PSORIASIS (n=537) ACNE (n=202) BLISTERING DIS. (n=53) 
Variable Level OR 95% CI OR 95% CI OR 95% CI OR 95% CI 
          
Age 60+  REF. -- REF. -- REF. -- REF. -- 
 18-39 2.23 1.09-4.58 2.27 1.30-3.97 4.93 0.42-57.27 4.80 0.39-58.58 
 40-59 3.25 1.57-6.72 2.14 1.24-3.69 -- -- 3.06 0.61-15.40 
          
Gender Female REF. -- REF. -- REF. -- REF. -- 
 Male 1.30 0.82-2.06 1.25 0.84-1.85 2.42 1.00-5.89 0.90 0.19-4.13 
          
Severity Mild REF. -- REF. -- REF. -- REF. -- 
 Moderate 2.16 1.29-3.61 1.35 0.84-2.18 1.88 0.67-5.29 4.79 0.77-29.65 
 Severe 1.84 0.90-3.75 1.36 0.77-2.41 2.60 0.74-9.11 10.12 1.02-100.57 
          
Flare scalp No REF. -- REF. -- REF. -- REF. -- 
 Yes 1.06 0.62-1.82 1.05 0.71-1.56 0.97 0.26-3.61 2.24 0.35-14.45 
          
Flare hands No REF. -- REF. -- REF. -- REF. -- 
 Yes 1.18 0.73-1.92 1.09 0.72-1.64 1.16 0.21-6.40 1.61 0.29-8.97 
          
Itch No REF. -- REF. -- REF. -- REF. -- 
 Yes 2.66 1.27-5.57 1.86 1.14-3.03 3.81 1.41-10.28 0.30 0.04-2.02 
          
Anxiety No REF. -- REF. -- REF. -- REF. -- 
 Yes 1.71 1.02-2.86 1.98 1.25-3.12 1.32 0.50-3.51 1.88 0.33-10.79 
          
Depression No  REF. -- REF. -- REF. -- REF. -- 
 Yes 1.99 1.15-3.45 2.05 1.27-3.30 1.03 0.32-3.34 0.66 0.10-4.42 
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Figure 1. Prevalence of positive answers to question 9 of the DLQI (“Over the last week, how much has your skin caused any sexual difficulties?”) 
in different skin conditions.  
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